Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy - 1 Apr 2016

Fekih-Mrissa Najiba, Sayeh Aycha, Baffoun Anis, Beji Maher, Mrad Meriem, Hmida Jalel, Nsiri Brahim

Abstract excerpt

The cause of thrombosis in hemodialysis vascular access is considered to be of a multifactorial nature, including stenosis of the venous or arterial connection. Therefore, identification of relevant thrombotic risk factors could lead to an improved antithrombotic therapy. This case control study was performed to evaluate the relationship between Factor V (G1691A and A4070G) and Factor II polymorphisms and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Polymorphism, Genetic

Share to Prothrombin

Share to Renal Dialysis

Share to Risk Factors

Share to Thrombosis

Source

Identifiers

PMID: 27004938
DOI: 10.1111/1744-9987.12379

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients.PMID 27004938Read ↗

A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.Semantic proximity Read ↗

Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.Semantic proximity Read ↗

Role of genetic mutations in vascular access thrombosis among hemodialysis patients waiting for renal transplantation.Semantic proximity Read ↗

Endothelial nitric oxide synthase gene intron 4 (VNTR) polymorphism and vascular access graft thrombosis.Semantic proximity Read ↗

The association of genotype polymorphisms with vascular access patency in hemodialysis patients.Semantic proximity Read ↗

Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis.Semantic proximity Read ↗

Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis.Semantic proximity Read ↗

Update on genetic risk factors for thrombosis and atherosclerotic vascular disease.Semantic proximity Read ↗

The presence of PAI-1 4G/5G and ACE DD genotypes increases the risk of early-stage AVF thrombosis in hemodialysis patients.Semantic proximity Read ↗

Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension.Semantic proximity Read ↗

Is there a role of angiotensin-converting enzyme gene polymorphism in the failure of arteriovenous femoral shunts for hemodialysis?Semantic proximity Read ↗

The role of endothelial nitric oxide synthase gene G894T and intron 4 VNTR polymorphisms in hemodialysis patients with vascular access thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.